butyrate and glp 1 to combat obesity obesity‐associated metabolic disorders: Current status and future implications for therapeutic use - Deuren - 2022 - Obesity Reviews The Protective Role of Butyrate

64% below iron RDA, 72% below calcium RDA, only 1.4% met vitamin D recommendations

Obesity T2DM (Type 2 Diabetes mellitus)

This update, published in Clinical Gastroenterology and Hepatology, responds to the American Society of Anesthesiologists previous recommendation for patients to discontinue these diabetes and weight loss drugs prior to elective surgeries

These trends suggest that GLP-1s are reshaping treatment patterns most significantly in markets where few alternatives exist and where their effectiveness is increasingly valued

Please consult a healthcare professional before using any dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition